MarginsXMarginsX
Home › Markets › PTPI

Petros Pharmaceuticals, Inc. (PTPI)

PTPI is quoted over the counter, not listed on an exchange. Petros Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0026
-13.3% on the day
1-year return
-84.7%
Market cap
$110K
Nano cap. From the Nov 16, 2026 close × 42.4M shares (10-Q cover page, Aug 15, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerPTPI, quoted over the counter
SEC CIK0001815903
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNew York, NY
Incorporated inDE

Warning signs

Cash runway
11.3 months
$3.5M cash at June 30, 2026
Share count, 1 year
0.0%
2025-08-13 to 2026-08-15 · +50019.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued."
10-Q 2026-08-13
Cash and burn$3.5M cash; operating cash flow -$929K a quarter.Report 2026-06-30
Shares outstanding42,372,260 (2026-08-15); 42,372,260 a year earlier; 2,113,570 three years earlier. 3y figure adjusted for splits (1-for-25 overall).Cover page 2026-08-15
Reverse splits, 3 years1; latest 1-for-25 on 2025-05-01Source 2025-05-01
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-11-20
AuditorHTL International, LLC, Houston, Texas, United States; changed auditors 2 times in 24 months8-K 4.01 2025-09-05
Late filings, 12 months1 NT noticeNT 10-K 2026-03-31
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$956K-$864K$3.5MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$987K-$784K$4.4MNo debt tagsNeeds four quarters10-Q 2026-05-13
Q4 2025
2025-12-31
Not filed-$337K-$934K$5.1MNo debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$923K-$1.1M$6.1MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed$5.4M-$3.0M$7.3MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$2.3M-$1.7M$8.9M$7.2MNeeds four quarters10-Q 2026-05-13
Q4 2024
2024-12-31
$725K-$9.3M$965K$1.7M$14.4M$5.1M10-K 2025-03-31
Q3 2024
2024-09-30
$1.6M-$2.2M-$771K$3.9M$2.3M$4.0M10-Q 2024-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-02-19
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K2026-09-30
Latest proxyDEF 14A2025-03-18

Source: SEC EDGAR submissions feed, 257 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier